Industry Fury As UK Watchdog Curbs Alzheimer Drugs

Britain's cost-effectiveness health watchdog said Tuesday it wants to limit access to the four main drugs used to treat patients with Alzheimer's disease, to the fury of pharmaceutical manufacturers. The National Institute for Clinical Excellence (NICE) recommended that doctors should stop giving the drugs to new patients because they are not cost effective.

Yahoo News (http://news.yahoo.com/news?tmpl=story&u=/nm/20050301/hl_nm/health_britain_alzheimers_dc_1)